DE69531103D1 - Für kreislauferkrankungen vorbeugendes mittel - Google Patents

Für kreislauferkrankungen vorbeugendes mittel

Info

Publication number
DE69531103D1
DE69531103D1 DE69531103T DE69531103T DE69531103D1 DE 69531103 D1 DE69531103 D1 DE 69531103D1 DE 69531103 T DE69531103 T DE 69531103T DE 69531103 T DE69531103 T DE 69531103T DE 69531103 D1 DE69531103 D1 DE 69531103D1
Authority
DE
Germany
Prior art keywords
preventive agent
diseases
circular
circular diseases
preventive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69531103T
Other languages
English (en)
Other versions
DE69531103T2 (de
Inventor
Ryuji Sugai
Umeji Murakami
Yukio Yamori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kracie Pharma Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Application granted granted Critical
Publication of DE69531103D1 publication Critical patent/DE69531103D1/de
Publication of DE69531103T2 publication Critical patent/DE69531103T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69531103T 1994-04-19 1995-04-18 Für kreislauferkrankungen vorbeugendes mittel Expired - Lifetime DE69531103T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10448094 1994-04-19
JP10448094 1994-04-19
PCT/JP1995/000750 WO1995028425A1 (fr) 1994-04-19 1995-04-18 Medicament preventif des maladies circulatoires

Publications (2)

Publication Number Publication Date
DE69531103D1 true DE69531103D1 (de) 2003-07-24
DE69531103T2 DE69531103T2 (de) 2004-05-19

Family

ID=14381732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69531103T Expired - Lifetime DE69531103T2 (de) 1994-04-19 1995-04-18 Für kreislauferkrankungen vorbeugendes mittel

Country Status (8)

Country Link
US (1) US5703212A (de)
EP (1) EP0757993B1 (de)
JP (1) JP3090950B2 (de)
AU (1) AU693544B2 (de)
DE (1) DE69531103T2 (de)
ES (1) ES2202359T3 (de)
NZ (1) NZ283815A (de)
WO (1) WO1995028425A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514941B1 (en) 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides
WO2019160023A1 (ja) * 2018-02-16 2019-08-22 森永乳業株式会社 脳卒中予防用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171052A (en) * 1968-03-18 1969-11-19 Louis Anne Gerhard Hissink Injectable Anti-Shock Preparation.
US4161520A (en) * 1976-10-14 1979-07-17 Hoffmann-La Roche Inc. Method of treating hypertension
US4361564A (en) * 1978-11-30 1982-11-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
JPS6023085B2 (ja) * 1981-12-23 1985-06-05 工業技術院長 アンジオテンシン転換酵素阻害剤
JPS62270533A (ja) * 1986-05-20 1987-11-24 Agency Of Ind Science & Technol 経口摂食物
SE8702550D0 (sv) * 1987-06-18 1987-06-18 Anders Grubb Cysteinproteashemmare
JPS645497A (en) * 1987-06-27 1989-01-10 Kanebo Ltd Collection of peptide
JPH04341193A (ja) * 1991-05-14 1992-11-27 Kanebo Ltd ペプチド又はその塩の取得方法
JPH06211690A (ja) * 1993-01-21 1994-08-02 Kanebo Ltd 血中脂質抑制用摂食物

Also Published As

Publication number Publication date
DE69531103T2 (de) 2004-05-19
NZ283815A (en) 1998-03-25
AU2224595A (en) 1995-11-10
JP3090950B2 (ja) 2000-09-25
EP0757993B1 (de) 2003-06-18
US5703212A (en) 1997-12-30
WO1995028425A1 (fr) 1995-10-26
EP0757993A4 (de) 1998-10-14
EP0757993A1 (de) 1997-02-12
AU693544B2 (en) 1998-07-02
ES2202359T3 (es) 2004-04-01

Similar Documents

Publication Publication Date Title
DE69521082D1 (de) Metallisches bakterizides Mittel
DE59505556D1 (de) Verteilvorrichtung für Häcksler
DK0707793T3 (da) Antimikrobielt middel
DE69740041D1 (de) Duftfreisetzungssysteme für körperpflegeartikel
ATE174340T1 (de) Antiparasitäre mittel
DE59508511D1 (de) Gitterwerk für orthopädisch-traumatologische Chirurgie
NO952749L (no) Middel for vannbehandling
DE69534990D1 (de) Kontrastmittel
DE825845T1 (de) Medizinisches gerät für die hand
DE69814907D1 (de) Chirurgische zugangsvorrichtung für die hand
DE69305615T2 (de) Parfümiertes mittel
DE69716838D1 (de) Diagnostisches Mittel für Diabetes
DE69524138T2 (de) Hautbehandlungsmittel
DE69506120T2 (de) Desinfektionsmittel
DE69518037D1 (de) Klebstoffmischung für die Zahnbehandlung
DE69528445D1 (de) Anti-mikrobielles Mittel
DE69520235D1 (de) Schweisshemmende mittel
DE69534145D1 (de) Sanitätsvorrichtung für rinderzitzen
DE69608864T2 (de) Mittel für die Wasserbehandlung
DE69627332D1 (de) Verbesserte phenolische vorvernetzungshemmende mittel
DE69531103D1 (de) Für kreislauferkrankungen vorbeugendes mittel
DE69714692D1 (de) Antimokrobielles Mittel für Nahrungsmittel
DE69516068D1 (de) Antikariogenisches Mittel
KR970703764A (ko) 항균제(antibacterial agents)
DE69617918T2 (de) Vorbeugendes/heilendes mittel für lebererkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: KANEBO SEIYAKU,LTD., TOKIO, JP